Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods

Clinical Biochemistry

Volumn 44, Issue 2-3, 2011, Pages 231-236

  Sallustio, Benedetta C ^a,b   Noll, Benjamin D ^a   Morris, Raymond G ^a,b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Everolimus; Immunoassays; LC MS MS; Sirolimus; Tacrolimus

Indexed keywords

32 DESMETHOXYRAPAMYCIN; ASCOMYCIN; EVEROLIMUS; RAPAMYCIN; RAPAMYCIN DERIVATIVE; TACROLIMUS; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ACCURACY; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; REPRODUCIBILITY; SOLID PHASE EXTRACTION; ULTRAVIOLET SPECTROSCOPY; BLOOD; DRUG MONITORING; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; EVEROLIMUS; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; SIROLIMUS; TACROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 79151475788     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.10.005     Document Type: Article

References (31)

1. Oellerich M., Armstrong V.W. The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: recent developments. Ther Drug Monit 2006, 28:720-725.
2. Baldelli S., Crippa A., Gabrieli R., et al. Comparison of the Innofluor Certican assay with HPLC-UV for the determination of everolimus concentrations in heart transplantation. Clin Biochem 2006, 39:1152-1159.
3. Bouzas L., Tutor J.C. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay. Clin Biochem 2007, 40:132-136.
4. Khoschsorur G., Fruehwirth F., Zeler S., Stettin M., Halwachs-Baumann G. Comparison of fluorescence polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation. Clin Chim Acta 2007, 380:217-221.
5. Murthy J.N., Davis D.L., Yatscoff R.W., Soldin S.J. Tacrolimus metabolite cross-reactivity in different tacrolimus assays. Clin Biochem 1998, 31:613-617.
6. Jones K., Saadat-Lajervardi S., Lee T., et al. An immunoassay for the measurement of sirolimus. Clin Ther 2000, 22(Suppl B):B49-B61.
7. Strom T., Haschke M., Boyd J., et al. Crossreactivity of isolated everolimus metabolites with the Innofluor Certican immunoassay for therapeutic drug monitoring of everolimus. Ther Drug Monit 2007, 29:743-749.
8. Salm P., Taylor P.J., Pillans P.I. The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle immunoassay in renal transplant recipients. Clin Ther 2000, 22(Suppl B):B71-B85.
9. Kuzuya T., Ogura Y., Motegi Y., Noriyama N., Nabeshima T. Interference of hematocrit in the Tacrolimus II microparticle enzyme immunoassay. Ther Drug Monit 2002, 24:507-511.
10. Brown N.W., Gonde C.E., Adams J.E., Tredger J.M. Low hematocrit and serum albumin concentrations underlie the overestimation of tacrolimus concentrations by microparticle enzyme immunoassay versus liquid chromatography-tandem mass spectrometry. Clin Chem 2005, 51:586-592.
11. Moes D.J.A.R., Press R.R., de Fijter J.W., Guchelaar H.-J., den Hartigh J. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation. Ther Drug Monit 2010, 32:413-419.
12. Salm P., Warnholtz C., Boyd J., Arabshahi L., Marbach P., Taylor P.J. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients. Clin Biochem 2006, 39:732-738.
13. Cogill J.L., Taylor P.J., Westley I.S., Morris R.G., Lynch S.V., Johnson A.G. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998, 44:1942-1946.
14. Ghoshal A.K., Soldin S.J. IMx tacrolimus II assay: is it reliable at low blood concentrations? A comparison with tandem MS/MS. Clin Biochem 2002, 35:389-392.
15. Sallustio B.C. LC-MS/MS for immunosuppressant therapeutic drug monitoring. Bioanalysis 2010, 2:1141-1153.
16. Wallemacq P.E., Vanbinst R., Adta S., Cooper D.P. High-throughput liquid chromatography-tandem mass spectrometric analysis of sirolimus in whole blood. Clin Chem Lab Med 2003, 41:921-925.
17. Korecka M., Solari S.G., Shaw L.M. Sensitive, high throughput HPLC-MS/MS method with on-line sample clean-up for everolimus measurement. Ther Drug Monit 2006, 28:484-490.
18. Keevil B.G., McCann S.J., Cooper D.P., Morris M.R. Evaluation of a rapid micro-scale assay for tacrolimus by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem 2002, 39:487-492.
19. Salm P., Taylor P.J., Lynch S.V., Warnholtz C.R., Pillans P.I. A rapid HPLC-mass spectrometry cyclosporin method suitable for current monitoring practices. Clin Biochem 2005, 38:667-673.
20. Taylor P.J., Johnson A.G. Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid-chromatography-electrospray tandem mass spectrometry. J Chromatogr B 1998, 718:251-257.
21. Streit F., Armstrong V.W., Oellerich M. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem 2002, 48:955-958.
22. Koal T., Deters M., Casetta B., Kaever V. Simultaneous determination of four immunosuppressants by means of high speed and robust on-line solid phase extraction-high performance liquid chromatography-tandem mass spectrometry. J Chromatogr B 2004, 805:215-222.
23. Koster R.A., Dijkers E.C., Uges D.R. Robust high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood. Ther Drug Monit 2009, 31:116-125.
24. French D.C., Saltzgueber M., Patel A., Hicks D.R., Lee T., Holt D.W. A simple HPLC-UV assay for TDM of sirolimus. Clin Chem 2001, 47:1316-1319.
25. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effects in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75:3019-3030.
26. Holt D.W., Lee T., Jones K., Johnston A. Validation of an assay for routine monitoring of sirolimus using HPLC with mass spectrometric detection. Clin Chem 2000, 46:1179-1183.
27. Taylor P.J., Salm P., Lynch S.V., Pillans P.I. Simultaneous quantification of tacrolimus and sirolimus, in human blood, by high-performance liquid chromatography-tandem mass spectrometry. Ther Drug Monit 2000, 22:608-612.
28. Annesley T.M., Clayton L. Simple extraction protocol for analysis of immunosuppressant drugs in whole blood. Clin Chem 2004, 50:1845-1848.
29. Ceglarek U., Lembcke J., Fielder G.M., et al. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta 2004, 346:181-190.
30. Shah V.P., Midha K.K., Dighe S., et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. J Pharm Sci 1992, 81:309-312.
31. Salm P., Rutherford D.M., Taylor P.J., Black M.J., Pillans P.I. Evaluation of microparticle enzyme immunoassay against HPLC-mass spectrometry for the determination of whole-blood tacrolimus in heart- and lung-transplant recipients. Clin Biochem 2000, 33:557-562.